JCI - Citations to Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Citations to this article

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

T Hercend, … , S F Schlossman, J Ritz

Published March 1, 1985
Citation Information: J Clin Invest. 1985;75(3):932-943. https://doi.org/10.1172/JCI111794.

View: Text | PDF

Research Article

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Text
PDF

Abstract

The initial characterization of two monoclonal antibodies directed at antigens selectively expressed on large granular lymphocytes (LGL) is reported in the present paper. These two reagents, anti-natural killer (NK) H1A and anti-NKH2, were obtained following immunization of mouse spleen cells with a cloned human NK cell line termed JT3. In fresh human peripheral blood, both anti-NKH1A and anti-NKH2 selectively reacted with cells that appeared morphologically as large granular lymphocytes. However, complement lysis studies and two color fluorescence analysis demonstrated that some LGL express both antigens and other cells express only NKH1A or NKH2. Functional analysis of these subsets indicated that the population of NKH1A+ cells contains the entire pool of NK active lymphocytes, whereas expression of NKH2 antigen appeared to delineate a unique subpopulation of LGL which, in a resting state, display a low degree of spontaneous cytotoxicity. Expression of NKH1A and NKH2 was also investigated using a series of nine well characterized human NK clones. All NK clones were found to be NKH1A+ and four out of nine also expressed NKH2. These results strongly supported the view that NKH1A is a "pan-NK" associated antigen, and indicated that at least a fraction of cloned NKH2 + LGL are strongly cytotoxic. Anti-NKH1A was shown to have the same specificity as the previously described N901 antibody and was found here to precipitate a 200,000-220,000-mol wt molecule in SDS-polyacrylamide gel electrophoresis (PAGE) analysis. Anti-NKH2 was specific for a structure that migrates at 60,000 mol wt in SDS-PAGE analysis under reducing conditions. Two color immunofluorescence analysis of NKH1A, NKH2, and other NK-associated antigens (Leu7 and B73.1) demonstrated variable degrees of coexpression of these antigens, which confirmed that NKH1A and NKH2 define distinct cell surface structures. Anti-NKH1A and anti-NKH2 appear to be useful reagents for characterizing LGL present in human peripheral blood and for identifying functionally relevant subsets within this heterogeneous population of cytotoxic lymphocytes.

Authors

T Hercend, J D Griffin, A Bensussan, R E Schmidt, M A Edson, A Brennan, C Murray, J F Daley, S F Schlossman, J Ritz

Total citations by year

Year:	2023	2021	2019	2016	2015	2013	2011	2009	2008	2007	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987	1986	1985	1971	Total
Citations:	1	1	1	1	1	2	1	1	1	1	1	1	1	2	2	2	5	6	5	4	3	4	9	20	26	20	35	23	19	15	5	1	220

Citation information

Citations to this article (220)

Title and authors	Publication	Year
iPSC-based modeling of helicase deficiency reveals impaired cell proliferation and increased apoptosis after NK cell lineage commitment Seo S, Patil SL, Ahn YO, Armetta J, Hegewisch-Solloa E, Castillo M, Guilz NC, Patel A, Corneo B, Borowiak M, Gunaratne P, Mace EM		2023
Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice M Ghasemzadeh, A Ghasemzadeh, E Hosseini	Human Immunology	2021
ILCs in hematologic malignancies: Tumor cell killers and tissue healers B Blom, V van Hoeven, MD Hazenberg	Seminars in Immunology	2019
Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial YC Xu, Q Xu, JJ Li, XF Gu, XL Lin, L Sun, HM Lu, L Tang, Y Ma, Z Lu, HX Wang	Journal of Cancer Research and Clinical Oncology	2016
Mechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of Glutathione M Allen, C Bailey, I Cahatol, L Dodge, J Yim, C Kassissa, J Luong, S Kasko, S Pandya, V Venketaraman	Frontiers in immunology	2015
Identification of cytolytic CD161- CD56+ regulatory CD8 T cells in human peripheral blood D Hu, HL Weiner, J Ritz	PloS one	2013
Identification of Cytolytic CD161−CD56+ Regulatory CD8 T Cells in Human Peripheral Blood D Hu, HL Weiner, J Ritz, F Annunziato	PloS one	2013
Advances in Immunology E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné	Advances in Immunology Volume 110	2011
Sleep as a mediator in the pathway from violence-induced traumatic stress to poorer health and functioning: a review of the literature and proposed conceptual model JC Spilsbury	Behavioral Sleep Medicine	2009
NK cells and their receptors WM Yokoyama, JK Riley	Reproductive BioMedicine Online	2008
A Soluble Form of the MHC Class I-Specific CD160 Receptor Is Released from Human Activated NK Lymphocytes and Inhibits Cell-Mediated Cytotoxicity J Giustiniani, A Marie-Cardine, A Bensussan	Journal of immunology (Baltimore, Md. : 1950)	2007
CD56-Positive Acute Lymphoblastic Leukemia S Matano, S Terahata, S Nakamura, K Kobayashi, T Sugimoto	Acta Haematologica	2005
Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome H Chang, J Brandwein, QL yi, K Chun, B Patterson, B Brien	Leukemia Research	2004
CD56 Expression in Feline Lymphoid Cells M SHIMOJIMA, Y NISHIMURA, T MIYAZAWA, K KATO, Y TOHYA, H AKASHI	Journal of Veterinary Medical Science	2003
Medical immunology: a new journal for a new subspecialty KA Smith	Medical immunology (London, England)	2002
CD56+, NKp46+ cell line (MZ93) expressing T-cell and myeloid antigens S Hashimoto, K Toba, J Tsuchiyama, T Abe, T Yano, A Momoi, K Okazuka, N Kanazawa, M Takahashi, Y Aizawa	Leukemia Research	2002
Head and Neck Cancer A Forastiere, W Koch, A Trotti, D Sidransky	New England Journal of Medicine	2001
Blood and alveolar lymphocyte subsets in pulmonary cytomegalovirus infection after lung transplantation F Stéphan, JF Bernaudin, D Cesari, A Fajac, D Grenet, I Caubarrere, M Stern	BMC Infectious Diseases	2001
The relationship between the frequency of the common cold and the activities of natural killer cells M Xu, T Muto, T Yabe, F Nagao, Y Fukuwatart, K Okumura	Environmental Health and Preventive Medicine	2000
Role of Natural Killer Cells in the Development of Graft-Versus-Host Disease JS Bryson, DL Flanagan	Journal of Hematotherapy & Stem Cell Research	2000
Long-term decrease of CD4+CD45RA+ T cells and impaired primary immune response after post-traumatic splenectomy HM Wolf, MM Eibl, E Georgi, A Samstag, M Spatz, S Uranus, R Passl	British Journal of Haematology	1999
CD4+ CD56+ Cutaneous Neoplasms: A Distinct Hematological Entity? T Petrella, S Dalac, M Maynadié, F Mugneret, E Thomine, P Courville, P Joly, B Lenormand, L Arnould, J Wechsler, M Bagot, C Rieux, J Bosq, MF Avril, A Bernheim, T Molina, A Devidas, MH Delfau-Larue, P Gaulard, D Lambert	The American Journal of Surgical Pathology	1999
CD56 identifies monocytes and not natural killer cells in rhesus macaques DL Carter, TM Shieh, RL Blosser, KR Chadwick, JB Margolick, JE Hildreth, JE Clements, MC Zink	Cytometry	1999
Specific skin manifestations in CD56 positive acute myeloid leukemia H Kuwabara, M Nagai, G Yamaoka, H Ohnishi, K Kawakami	Journal of Cutaneous Pathology	1999
Costimulation of human natural killer cells is required for interferon gamma production TA Fehniger, WE Carson, MA Caligiuri	Transplantation Proceedings	1999
Characterization of unmyelinated axons uniting epidermal and dermal immune cells in primate and murine skin CL Egan, MJ Viglione-Schneck, LJ Walsh, B Green, JQ Trojanowski, D Whitaker-Menezes, GF Murphy	Journal of Cutaneous Pathology	1998
Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti-inflammatory role K Arai, S Yamamura, S Seki, T Hanyu, HE Takahashi, T Abo	Clinical & Experimental Immunology	1998
Fetal natural killer cell function is suppressed E Dominguez, JA Madrigal, Z Layrisse, SB Cohen	Immunology	1998
Do Primary Cutaneous Non-T Non-B CD4+CD56+ Lymphomas Belong to the Myelo-Monocytic Lineage? M Bagot, A Bouloc, D Charue, J Wechsler, A Bensussan, L Boumsell	Journal of Investigative Dermatology	1998
CD2−, CD4+, CD56+ Agranular Natural Killer Cell Lymphoma of the Skin N Uchiyama, K Ito, K Kawai, F Sakamoto, M Takaki, M Ito	The American Journal of Dermatopathology	1998
CD4 + T Cell and Natural Killer Cell-dependent Killing of Mycobacterium tuberculosis by Human Monocytes T Yoneda, JJ Ellner	American journal of respiratory and critical care medicine	1998
CD56bright natural killer cell subsets: Characterization of distinct functional responses to interleukin-2 and the c-kit ligand WE Carson, TA Fehniger, MA Caligiuri	European Journal of Immunology	1997
The significance of the ratio of lymphocyte subsets, CD56 + CD16 + Cell, CD56 + Cell, CD16 + Cell in patients with malignant tumors T Ozaki, K Tabuse, K Mori, T Tsuji, M Uenishi, E Ishimaru, H Ichikawa, H Tanaka, S Yamazoe, T Shimamoto, O Saeki, K Toyoda	Journal of Microwave Surgery	1997
Changes in lymphocyte subsets in patients suffering from hepatocellular carcinoma with liver cirrhosis after microwave coagulation therapy T Ozaki, K Tabuse, M Uenishi, K Mori, T Tsuji, T Hotta, E Ishimaru, S Sakakura, M Nakamura, H Ichikawa, H Tanaka, S Yamazoe, T Shimamoto, I Fujiwara, K Ueda, H Nakai, O Saeki, K Toyoda, H Kusunoki	Journal of Microwave Surgery	1997
Posttraumatic Stress Symptoms, Intrusive Thoughts, Loss, and Immune Function after Hurricane Andrew: G Ironson, C Wynings, N Schneiderman, A Baum, M Rodriguez, D Greenwood, C Benight, M Antoni, A LaPerriere, HS Huang, N Klimas, MA Fletcher	Psychosomatic medicine	1997
CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Acute Leukemia: A Distinct Hematolymphoid Disease Entity R Suzuki, K Yamamoto, M Seto, Y Kagami, M Ogura, Y Yatabe, T Suchi, Y Kodera, Y Morishima, T Takahashi, H Saito, R Ueda, S Nakamura	Blood	1997
A novel monoclonal antibody mNI-58A against the α-chain of leukocyte function-associated antigen-1 (LFA-1) blocks the homotypic cell aggregation and actively regulates morphological changes in the ohorbol myristate acetate (PMA)-activated human monocyte-like cell line, U937 N Ikewaki, A Yamada, A Sonoda, H Inoko	Tissue Antigens	1996
CD48 May serve as an accessory molecule for the activation of a subset of human γ/δ T cells C Flament, K Bellagha, A Rosenthal-Allieri, S Chouaib, F Mami-Chouaib	Human Immunology	1996
Feγ-Receptor III (CD16) is Involved in NK-8 Cell Interaction P Lenz, JE Gessner, C Sautes, RE Schmidt	Immunobiology	1996
Impaired recovery and cytolytic function of CD56+T and non—T cells in systemic lupus erythematosus following in vitro polyclonal T cell stimulation. Studies in unselected patients and monozygotic disease-discordant twins W Stohl, JE Elliott, AS Hamilton, DM Deapen, TM Mack, DA Horwitz	Arthritis & Rheumatism	1996
Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection B Lucia, C Jennings, R Cauda, L Ortona, AL Landay	Cytometry	1995
Origin of CD57+ T cells which increase at tumour sites in patients with colorectal cancer T Okada, T Iiai, Y Kawachi, T Moroda, Y Takii, K Hatakeyama, T Abo	Clinical & Experimental Immunology	1995
Expression of N-CAM (CD56) on Acute Leukemia Cells: Relationship with Disease Chracteristics and Outcome X Thomas, L Vila, L Campos, O Sabido, E Archibaud	Leukemia & Lymphoma	1995
Extrathymic Pathways of T-cell Differentiation in the Liver and Other Organs T Abo, H Watanabe, T Iiai, M Kimura, K Ohtsuka, K Sato, M Ogawa, H Hirahara, S Hashimoto, H Sekikawa, S Seki	International Reviews of Immunology	1994
Adhesion of Follicular Lymphoma Cells to Lymphoid Germinal Centers—A Potential Mechanism of Tumor Cell Homing Following Autologous Transplantation AS Freedman, L Saporito, K Rhynhart, C Morimoto, LM Nadler	Leukemia & Lymphoma	1994
Interleukin-8 and Related Chemotactic Cytokines M Baggiolini, B Moser, I Clark-Lewis	Chest	1994
Complementary DNA sequence encoding the major neural cell adhesion molecule isoform in a human small cell lung cancer cell line S Saito, Y Tanio, I Tachibana, S Hayashi, T Kishimoto, I Kawase	Lung cancer (Amsterdam, Netherlands)	1994
Intercellular immune adhesion molecules in human liver transplants: Overview on expression patterns of leukocyte receptor and ligand molecules G Steinhoff, M Behrend, B Schrader, R Pichlmayr	Hepatology	1993
A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity H Maïza, G Leca, IG Mansur, V Schiavon, L Boumsell, A Bensussan	Journal of Experimental Medicine	1993
NCAM (CD56)-Positive Malignant Lymphoma WF Kern, CM Spier, TP Miller, TM Grogan	Leukemia & Lymphoma	1993
Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study L Bergmann, K Fenchel, E Weidmann, HM Enzinger, B Jahn, D Jonas, PS Mitrou	Cancer	1993
Lymphokine-Activated Killer Cells: Biology and Relevance to Disease JC Hiserodt	Cancer Investigation	1993
Augmentation of human natural killer cells by splenopentin analogs A Rastogi, VK Singh, S Biswas, W Haq, KB Mathur, SS Agarwal	FEBS Letters	1993
Analysis of Peripheral Blood Lymphocyte Cell Surface Density of Functional and Activation Associated Markers in Young and Old Hemodialysis Patients M Shabtai, I Avigad, P Schachter, A Czerniak, A Judich, A Ayalon	The Journal of Urology	1993
Fibre type specific expression of Leu19-antigen and N-CAM in skeletal muscle in various stages after experimental denervation W Müller-Felber, K Küllmer, P Fischer, CD Reimers, S Wagner, U Harland, M Schmidt-Achert, D Pongratz	Virchows Archiv A Pathological Anatomy and Histopathology	1993
Generation of Allospecific Natural Killer Cells by Stimulation Across a Polymorphism of HLA-C M Colonna, EG Brooks, M Falco, GB Ferrara, JL Strominger	Science	1993
Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells R Leo, M Boeker, D Peest, R Hein, R Bartl, JE Gessner, J Seibach, G Wacker, H Deicher	Annals of Hematology	1992
The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria EA van Tol, HW Verspaget, AS Pena, CV Kraemer, CB Lamers	European Journal of Immunology	1992
Expression of cytolytic mediators by synovial fluid lymphocytes in rheumatoid arthritis LH Young, SV Joag, PY Lin, SF Luo, LM Zheng, CC Liu, JD Young	The American Journal of Pathology	1992
Cells with natural killer activity in human rabies T Panpanich, T Hemachudha, S Piyasirisilp, S Manatsathit, H Wilde, P Phanuphak	Clinical & Experimental Immunology	1992
Phenotypic and clinical heterogeneity of CD56-positive acute nonlymphoblastic leukemia MA Reuss-Borst, B Steinke, HD Waller, HJ Bühring, CA Müller	Annals of Hematology	1992
Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells I Illa, M Leon-Monzon, MC Dalakas	Annals of Neurology	1992
Studies on NK cell purification by negative selection in human peripheral blood F Farace, AM Ridant, B Escudier, T Hercend, F Triebel	Biotherapy	1992
CD3.TCR1, A Human CD3 epitope expressed on viable lymphocytes exclusively C Miossec, C Genevee, T Hercend, S Jitsukawa	Cellular Immunology	1992
High percentage of CD8+, Leu-7+ cells in rheumatoid arthritis synovial fluid CM Burns, V Tsai, NJ Zvaifler	Arthritis & Rheumatism	1992
Tissue reactivity of anti-Leu19 D Fischler, T Bauer, R Tubbs	Histopathology	1992
TiγA+δTCS1+ T cells in human thymus. Analysis of the T cell receptor R Bosse, H Heiken, W Kolanus, P Delany, RE Schmidt, F Triebel	European Journal of Immunology	1992
Cyclic amp upregulates mRNA and surface expression of IL-2Rα p55(Tac) in normal human NK cell clones I Vitté-Mony, A Goy, L Guizani, JH Bertoglio	Molecular Immunology	1992
Antibodies Raised Against Peptide Fragments of CD16 Reacting with Membrane and Soluble Form of CD16. I: Production and Characterization R Mouawad, S Visonneau, C SOUBRANE, P Hirel, B Autran, J Marceau-Suissa, M Weil, D Khayat	Hybridoma	1992
Distribution of Leu-19(CD56) Natural Killer Lymphocyte Antigen in Cultured Cells from the Human Embryonic Central Nervous System F Aloisi, P Samoggia, E Montesoro, U Testa, G Levi, C Peschle	Annals of the New York Academy of Sciences	1992
Impaired generation of polyclonal T cell-mediated cytolytic activity despite normal polyclonal T cell proliferation in systemic lupus erythematosus W Stohl	Clinical Immunology and Immunopathology	1992
Stimulation of human peripheral blood mononuclear cells with anti-CD3 monoclonal antibody vs IL2: Disparate effects on T cell-dependent B cell differentiation despite similar effects on generation of unrestricted cytolytic activity W Stohl, JE Elliott	Clinical Immunology and Immunopathology	1992
Human NK Cells in Health and Disease: Clinical, Functional, Phenotypic and DNA Genotypic Characteristics SJ Richards, CS Scott	Leukemia & Lymphoma	1992
Non HLA-Restricted Cytotoxic Cells and Their Modulation in Acute Myelogenous Leukemia E Archimbaud	Leukemia & Lymphoma	1992
Diagnostische Hämatologie H Huber, H Löffler, D Pastner		1992
Establishment and characterization of Macaca fascicularis lymphoblastoid cell lines CH Manning, ER Heise	Journal of Medical Primatology	1992
Immunologic function in a cohort of human immunodeficiency virus type 1-seropositive and -negative healthy homosexual men NG Klimas, P Caralis, A LaPerriere, MH Antoni, G Ironson, J Simoneau, N Schneiderman, MA Fletcher	Journal of clinical microbiology	1991
Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells N Suzuki, T Suzuki, EG Engleman	Journal of Experimental Medicine	1991
Detection of Leu-19 (CD56) antigen on human thyroid epithelial cells by an immunohistochemical method K Migita, K Eguchi, A Kawakami, H Ida, T Fukuda, A Kurata, N Ishikawa, K Ito, S Nagataki	Immunology	1991
Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome LJ Morrison, WH Behan, PO Behan	Clinical & Experimental Immunology	1991
Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma L Ferradini, S Miescher, M Stoeck, P Busson, C Barras, N Cerf-Bensussan, M Lipinski, VV Fliedner, T Tursz	International Journal of Cancer	1991
Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones S Ferrini, I Prigione, S Miotti, E Ciccone, C Cantoni, Q Chen, MI Colnaghi, L Moretta	International Journal of Cancer	1991
Human Natural Killer Cells Express Different Integrins and Spread on Fibronectin I Virtanen, J Ylanne, T Vartio, E Saksela	Scandinavian Journal of Immunology	1991
Immunocytochemical characterization of large granular lymphocytes in normal cervix and HPV associated disease J McKenzie, A King, J Hare, T Fulford, B Wilson, M Stanley	The Journal of Pathology	1991
Cytotoxic activity and phenotypic characteristics of lymphocyte subsets after therapy of cancer patients with interleukin-2 E Weidmann, L Bergmann, P Hechler, PS Mitrou	Cancer Immunology Immunotherapy	1991
Two monoclonal antibodies against small-cell lung cancer show existence of synergism in binding S Saito, T Inoue, I Kawase, H Hara, Y Tanio, I Tachibana, S Hayashi, M Watanabe, M Matsunashi, T Osaki, T Masuno, S Kishimoto	Cancer Immunology Immunotherapy	1991
In vitro enhancement of natural cytotoxicity by a trial natriuretic peptide fragment 4–28 RB Moss, MG Golightly	Peptides	1991
Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway AS Freedman, GJ Freeman, K Rhynhart, LM Nadler	Cellular Immunology	1991
Ultrastructural localization of interferon-producing cells in the livers of patients with chronic hepatitis B HP Dienes, G Hess, M Wöorsdörfer, S Rossol, H Gallati, G Ramadori, KH Büschenfelde	Hepatology	1991
CD2 is functionally linked to the ζ-natural killer receptor complex E Vivier, PM Morin, C O'Brienm, SF Schlossman, P Anderson	European Journal of Immunology	1991
Activation of CD16+ effector cells by rheumatoid factor complex. Role of natural killer cells in rheumatoid arthritis C Hendrich, JG Kuipers, W Kolanus, RE Schmidt, M Hammer	Arthritis & Rheumatism	1991
Prolonged Interleukin-2 (IL-2) Treatment Can Augment Immune Activation Without Enhancing Antitumor Activity in Renal Cell Carcinom JA Sosman, JA Hank, KH Moore, A Borchert, K Schell, PC Kohler, D Goldstein, R Bechhofer, B Storer, MR Albertini, PE Leung, D Levitt, PM Sondel	Cancer Investigation	1991
Expression of Class II-MHC Antigens in the Dermis of Patients with Progressive Systemic Sclerosis M Gruschwitz, N Sepp, H Kofler, G Wick	Immunobiology	1991
Defective CD2 pathway T cell activation in systemic lupus erythematosus DA Fox, JA Millard, J Treisman, W Zeldes, A Bergman, J Depper, R Dunne, WJ McCune	Arthritis & Rheumatism	1991
Immune function and anti-HTLV-I/II status in anti-HIV-1 -negative intravenous drug users receiving methadone NG Klimas, NT Blaney, RO Morgan, D Chitwood, K Milles, H Lee, MA Fletcher	The American Journal of Medicine	1991
The effects of recombinant human granulocyte-macrophage colony-stimulating factor on the induction of lymphokine-activated killer cells in vitro S Okamura, T Takeshi, S Yamaga, F Omori, N Yoshiyuki	International Journal of Immunopharmacology	1991
Identification of a population of large granular lymphocytes obtained from the rheumatoid joint coexpressing the CD3 and CD16 antigens RA Bray, RM Pope, AL Landay	Clinical Immunology and Immunopathology	1991
Cellular toxicity of sulfamethoxazole reactive metabolites—II JS Leeder, A Nakhooda, SP Spielberg, HM Dosch	Biochemical Pharmacology	1991
Mechanisms of depressed natural killer cell activity in recurrent aphthous ulcers A Sun, CT Chu, YC Wu, JH Yuan	Clinical Immunology and Immunopathology	1991
Blood Cell Biochemistry Volume 3 JR Harris		1991
Cytotoxic activity and phenotypic characteristics of lymphocyte subsets after therapy of cancer patients with interleukin-2 E Weidmann, L Bergmann, P Hechler, PS Mitrou	Cancer Immunology, Immunotherapy	1991
Two monoclonal antibodies against small-cell lung cancer show existence of synergism in binding S Saito, T Inoue, I Kawase, H Hara, Y Tanio, I Tachibana, S Hayashi, M Watanabe, M Matsunashi, T Osaki, T Masuno, S Kishimoto	Cancer Immunology, Immunotherapy	1991
Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen DA Fox, JA Millard, L Kan, WS Zeldes, W Davis, J Higgs, F Emmrich, RW Kinne	Journal of Clinical Investigation	1990
The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures MR van Brink, SS Boggs, RB Herberman, JC Hiserodt	Journal of Experimental Medicine	1990
Heterogeneity of human natural killer cells in the spleen T Witte, K Wordelmann, RE Schmidt	Immunology	1990
Immunologic abnormalities in chronic fatigue syndrome NG Klimas, FR Salvato, R Morgan, MA Fletcher	Journal of clinical microbiology	1990
Rotavirus induces proliferative response and augments non-specific cytotoxic activity of lymphocytes in humans M Yasukawa, O Nakagomi, Y Kobayashi	Clinical & Experimental Immunology	1990
A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function A Moretta, G Tambussi, C Bottino, G Tripodi, A Merli, E Ciccone, G Pantaleo, L Moretta	Journal of Experimental Medicine	1990
Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma F Farace, C Mathiot, M Brandely, T Tursz, T Dorval, P Pouillart, F Triebel, T Hercend, WH Fridman	Clinical & Experimental Immunology	1990
LAK activity is inducible in blood mononuclear cells from human fetus A Cossarizza, D Monti, F Dagna-Bricarelli, G Montagnani, C Franceschi	Immunology Letters	1990
Human Natural Killer Clones Enhance in Vitro Antibody Production by Tumour Necrosis Factor Alpha and Gamma Interferon JC Becker, W Kolanus, C Lonnemann, RE Schmidt	Scandinavian Journal of Immunology	1990
Cytotoxicity of purified leu 19+ cells from the peripheral blood of children with acute lymphocytic leukemia ZA Afify, A Abdel-Mageed, HW Findley, AH Ragab	Cancer	1990
Cytolytic activity of human natural killer cell subpopulations isolated by four-color immunofluorescence flow cytometric cell sorting EF Srour, T Leemhuis, L Jenski, R Redmond, J Jansen	Cytometry	1990
T cell receptor gene rearrangements of T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis (PBC): Oligoclonality of PBC-derived T cell clones U Moebius, M Manns, G Hess, G Kober, KH Büschenfelde, SC Meuer	European Journal of Immunology	1990
Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Tiγ/δ or TNK phenotype U Testa, A Care, E Montesoro, C Fossati, G Giannella, R Masciulli, M Fagioli, D Bulgarini, D Habetswallner, G Isacchi, PG Pelicci, C Peschle	Cancer Immunology Immunotherapy	1990
Characterization of Normal Human Lung Lymphocytes and Interleukin-2-induced Lung T Cell Lines S Becker, DT Harris, HS Koren	American journal of respiratory cell and molecular biology	1990
Leukocyte immunophenotyping by flow cytometry in a multisite study: Standardization, quality control, and normal values in the Transfusion Safety Study JW Parker, B Adelsberg, SP Azen, D Boone, MA Fletcher, GF Gjerset, J Hassett, J Kaplan, JC Niland, T Odom-Maryon, EA Operskalski, H Prince, D Scott, DP Stites, JW Mosley	Clinical Immunology and Immunopathology	1990
Combined immunodeficiency due to the selective absence of CD4 inducer T lymphocytes JW Sleasman, TF Tedder, DJ Barrett	Clinical Immunology and Immunopathology	1990
Immunobiology of Chronic Lymphocytic Leukemia AS Freedman	Hematology/Oncology Clinics of North America	1990
Cross-reactivity of monoclonal antibody Leu-19 with some neuroectodermal and other non-immune tissues R Nawrotzki, A Starzinski-Powitz, F Weber, R Schrder	Acta Neuropathologica	1990
A chronic ?postinfectious? fatigue syndrome associated with benign lymphoproliferation, B-cell proliferation, and active replication of human herpesvirus-6 D Buchwald, AS Freedman, DV Ablashi, JL Sullivan, M Caligiuri, DS Weinberg, CG Hall, RL Ashley, C Saxinger, N Balachandran, J Ritz, LM Nadler, AL Komaroff	Journal of Clinical Immunology	1990
Interleukin-2-dependent long-term cultures of low-density lymphocytes allow the proliferation of lymphokine-activated killer cells with natural killer, Tiγ/δ or TNK phenotype U Testa, A Care, E Montesoro, C Fossati, G Giannella, R Masciulli, M Fagioli, D Bulgarini, D Habetswallner, G Isacchi, PG Pelicci, C Peschle	Cancer Immunology, Immunotherapy	1990
Laboratory and clinical applications of monoclonal antibodies for leukemias and non-Hodkin's lymphoma KA Foon	Current Problems in Cancer	1989
The cellular immunotherapy of cancer: Current and potential uses of interleukin-2 PM Sondel, JA Hank, PC Kohler, JA Sosman, G Weil-Hillman, P Fisch, FH Bach	Critical Reviews in Oncology/Hematology	1989
Phenotypic and functional characterization of normal and malignant terminal B (plasma) cells KC Anderson, M Cochran, BA Barut	European Journal of Haematology	1989
Antibacterial activity of human natural killer cells P Garcia-Peñarrubia, FT Koster, RO Kelley, TD McDowell, AD Bankhurst	Journal of Experimental Medicine	1989
Suppression of in vitro immunoglobulin synthesis by CD16(Leu11a)+ CD56 (NKH1,Leu19)+non-T lineage NK cells; lack of suppression of cells from immunodeficient patients T Morio, S Nonoyama, J Yata	Clinical & Experimental Immunology	1989
Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction T Nitta, H Yagita, K Sato, K Okumura	Journal of Experimental Medicine	1989
Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule LL Lanier, R Testi, J Bindl, JH Phillips	Journal of Experimental Medicine	1989
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells WH Chambers, NL Vujanovic, AB DeLeo, MW Olszowy, RB Herberman, JC Hiserodt	Journal of Experimental Medicine	1989
Lymphocyte antigen Leu-19 as a molecular marker of regeneration in human skeletal muscle W Schubert, K Zimmermann, M Cramer, A Starzinski-Powitz	Proceedings of the National Academy of Sciences	1989
Interleukin-2 induced killer cell activity against Epstein-Barr virus-immortalized human B cells SK Kundu, J Menezes	Immunology Letters	1989
Natural killer lymphocyte blast crisis of chronic myelogenous leukemia MJ Warzynski, C White, MG Golightly, R Steingart, RN Otto, AE Podgurski, ML Johnson, P Glynn, DE Smith	American Journal of Hematology	1989
Surface Molecules Involved in the Activation and Regulation of T or Natural Killer Lymphocytes in Humans A Moretta, E Ciccone, G Pantaleo, G Tambussi, C Bottino, G Melioli, MC Mingari, L Moretta	Immunological Reviews	1989
Characteristics and uses of IL-2 in immunotherapy RL Bolhuis, G Stoter, AM Eggermont	Biotherapy	1989
Comprehensive quality assessment approach for flow cytometric immunophenotyping of human lymphocytes BS Edwards, KK Altobelli, HA Nolla, DA Harper, RR Hoffman	Cytometry	1989
Identification of a new surface molecule expressed by human LGL and LAK cells: Production of a specific monoclonal antibody and comparison with other NK/LAK markers MR Zocchi, A Poggi, S Mariani, E Gianazza, C Rugarli	Cellular Immunology	1989
CD 16 surface molecules regulate the cytolytic function of CD3−CD16+ human natural killer cells A Moretta, G Tambussi, E Ciccone, D Pende, G Melioli, L Moretta	International Journal of Cancer	1989
Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells A Moretta, E Ciccone, G Tambussi, C Bottino, O Viale, D Pende, A Santoni, MC Mingari	International Journal of Cancer	1989
Regulation of human B cell activation and antibody production by non-major histocompatibility complex-restricted cytotoxic T lymphocytes F Boué, C Goujard, J Delfraissy, P Galanaud, T Hercend	European Journal of Immunology	1989
Clonal evidence for the induction of NKH1 on activated human thymocytes MA Caligiuri, C Murray, H Levine, JA Longtine, J Ritz	European Journal of Immunology	1989
Phenotypic characterization of cynomolgus monkey natural killer cells YK Yamada, M Yabe, M Tatsumi	Cellular Immunology	1989
The T-cell receptor Vδ genes predominantly used by human peripheral γ/δ+ T lymphocytes are not rearranged in CD3− natural killer cells S Roman-Roman, E Baixeras, C Genevée, T Hercend, F Triebel	Human Immunology	1989
Biology of natural killer cells G Trinchieri	Advances in immunology	1989
Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells CA Biron, KS Byron, JL Sullivan	New England Journal of Medicine	1989
Human Pulmonary Natural Killer (NK) Cells Exhibit Limited Lymphokine-activated Killer (LAK) Activity WC Yarbrough, JC Weissler	American journal of respiratory cell and molecular biology	1989
The Role of Natural Killer Cells in Immune Surveillance J Ritz	New England Journal of Medicine	1989
Immunophenotyping in a multicenter study: The Transfusion Safety Study experience MA Fletcher, SP Azen, B Adelsberg, G Gjerset, J Hassett, J Kaplan, JC Niland, T Odom-Maryon, JW Parker, DP Stites, JW Mosley	Clinical Immunology and Immunopathology	1989
CD3-negative natural killer cells express ε TCR as part of a novel molecular complex P Anderson, M Caligiuri, J Ritz, SF Schlossman	Nature	1989
Increased peripheral blood leukocyte cytotoxic activity in cancer patients during the continuous intravenous administration of recombinant human tumor necrosis factor PS Charnetsky, RA Greisman, SE Salmon, EM Hersh, P Scuderi	Journal of Clinical Immunology	1989
Interleukin-2 (r-IL-2)-induced lymphokine-activated killer (LAK) cells and their precursors express the VGO1 antigen JF Denegri, J Peterson, P Tilley	Journal of Clinical Immunology	1989
Effect of interleukin-2 on the ex vivo growth of human myeloma cells D Peest, I de Vries, R Hölscher, R Leo, H Deicher	Cancer Immunology, Immunotherapy	1989
Functions of the Natural Immune System CW Reynolds, RH Wiltrout		1989
Modern Trends in Human Leukemia VIII: New Results in Clinical and Biological Research Including Pediatric Oncology R Neth, RC Gallo, MF Greaves, G Gaedicke, S Gohla, K Mannweiler, J Ritter		1989
CD16 + Lymphoblastic Cell Lines of Crab‐Eating Monkeys (Macaca fascicularis) Shared U‐5 Antigen and Expressed Natural Killer Activity Y Murayama, M Fujisaki, A Noguchi, O Takenaka	Journal of Medical Primatology	1989
Lymphokine activated killer cells A Lindemann, F Herrmann, W Oster, R Mertelsmann	Blut Zeitschrift für die Gesamte Blutforschung	1989
Biology of Natural Killer Cells Trinchieri G	Advances in immunology	1989
Subset of natural killer cells is induced by immune complexes to display Fc receptors for IgE and IgA and demonstrates isotype regulatory function H Kimata, A Saxon	Journal of Clinical Investigation	1988
Dual-label immunocytochemistry of the active multiple sclerosis lesion: Major histocompatibility complex and activation antigens T Hayashi, C Morimoto, JS Burks, C Kerr, SL Hauser	Annals of Neurology	1988
A simple guide to the terminology and application of leucocyte monoclonal antibodies JK Chan, CS Ng, PK Hui	Histopathology	1988
Surface proteins and glycoproteins of human leucocytes V Horejsí, V Bazil	Biochemical Journal	1988
Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2 S Chouaib, J Bertoglio, JY Blay, C Marchiol-Fournigault, D Fradelizi	Proceedings of the National Academy of Sciences	1988
Resting human peripheral blood lymphocytes can be activated to cytolytic function by antibodies to CD3 in the absence of exogenous interleukin-2 CF Scott, JM Lambert, S Bolender, WA Blattler	Cellular Immunology	1988
Immunophenotype of small cell lung carcinoma: Expression of NKH-1 and transferrin receptor and absence of most myeloid antigens MI Doria, AG Montag, WA Franklin	Cancer	1988
Anti-Leu 19 monoclonal antibody detects an antigen on autonomic nerves in human skin H Niedecken, W Wehrmann, R Bauer, HW Kreysel	Journal of Cutaneous Pathology	1988
Studies on the relationship of human natural killer and lymphokine-activated killer cells with lysosomal staining and analysis of surface marker phenotypes H Shau, JD Gray, MS Mitchell	Cellular Immunology	1988
Generation of lymphokine-activated killer cell activity from non-NK precursor cells FJ Ramsdell, RA Lindemann, H Shau, JD Gray, SH Golub	Cellular Immunology	1988
Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis SC Meuer, U Moebius, MM Manns, HP Dienes, G Ramadori, G Hess, T Hercend, KH Buschenfelde	European Journal of Immunology	1988
Cross-reactivity of monoclonal antibodies directed against lymphocyte markers with trophoblast cells of normal placenta, hydatidiform mole, and gestational choriocarcinoma RS Berkowitz, SA Umpierre, DP Goldstein, DJ Anderson	Gynecologic Oncology	1988
Radiosensitivity of NK lytic activities and NK-mediated hematopoietic colony inhibition: Effect of activation with IL-2 and blocking of the T-200 molecule CA Keever, E Benazzi, NA Kernan, K Welte, RJ O'Reilly, C Bordignon	Cellular Immunology	1988
Differential immunomodulation by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell activation: Dependence upon the individual anti-CD3 monoclonal antibody used for activation W Stohl, DN Posnett, N Chiorazzi	Cellular Immunology	1988
Mechanism of K562-induced human natural killer cell inactivation using highly enriched effector cells isolated via a new single-step sheep erythrocyte rosette assay SI Abrams, Z Brahmi	Annales de l'Institut Pasteur / Immunologie	1988
Clinical and Immunologic Effects of Monthly Administration of Intravenous Cyclophosphamide in Severe Systemic Lupus Erythematosus WJ McCune, J Golbus, W Zeldes, P Bohlke, R Dunne, DA Fox	New England Journal of Medicine	1988
Are cognitive receptors involved in ⪡non-specific⪢ MHC-unrestricted lytic activity? RL Bolhuis, E Braakman, RJ de Griend	Annales de l'Institut Pasteur / Immunologie	1988
Tumor cell lysis by T cells distinct from NK cells and alloantigen-specific cytotoxic T cells DL Thiele, PE Lipsky	Clinical Immunology and Immunopathology	1988
Human natural killer (NK) cells produce a late-acting B-cell differentiation activity H Kimata, EH Sherr, A Saxon	Journal of Clinical Immunology	1988
Histophysiology of the Immune System: The Life History, Organization, and Interactions of Its Cell Populations S Fossum, B Rolstad		1988
Immunochemical Approaches to Coastal, Estuarine and Oceanographic Questions CM Yentsch, FC Mague, PK Horan		1988
Modulation of intestinal immune reactivity by interleukin 2: Phenotypic and functional analysis of lymphokine-activated killer cells from human intestinal mucosa C Fiocchi, KR Youngman, B Yen-Lieberman, RR Tubbs	Digestive Diseases and Sciences	1988
Expression of markers shared between human natural killer cells and neuroblastoma lines RC McGarry, A Pinto, DR Hammersley-Straw, CL Trevenen	Cancer Immunology, Immunotherapy	1988
Enhancement of natural killer function through activation of the T11 E rosette receptor RE Schmidt, JM Michon, J Woronicz, SF Schlossman, EL Reinherz, J Ritz	Journal of Clinical Investigation	1987
Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen T Takeuchi, CE Rudd, SF Schlossman, C Morimoto	European Journal of Immunology	1987
A novel 120-kD surface antigen expressed by a subset of human lymphocytes. Evidence that lymphokine-activated killer cells express this molecule and use it in their effector function MR Zocchi, C Bottino, S Ferrini, L Moretta, A Moretta	Journal of Experimental Medicine	1987
A novel subset of human lymphocytes with a T cell receptor-gamma complex S Jitsukawa, F Faure, M Lipinski, F Triebel, T Hercend	Journal of Experimental Medicine	1987
Expression of natural killer cell markers in non-Hodgkin's lymphomas CS Ng, JK Chan, ST Lo	Human Pathology	1987
Definition of a secondary target cell trigger during natural killer cell cytotoxicity: Possible role of phospholipase A2 RL Deem, LJ Britvan, SR Targan	Cellular Immunology	1987
Modulation of ongoing human immunoglobulin synthesis by natural killer cells H Kimata, F Shanahan, M Brogan, S Targan, A Saxon	Cellular Immunology	1987
Cloned human CD3− lymphocytes with natural killerlike activity do not express nor rearrange T cell receptor gamma genes F Triebel, M Graziani, F Faure, S Jitsukawa, T Hercend	European Journal of Immunology	1987
Immunoelectron microscopic observations on the inflammatory infiltrates and HLA antigens in hepatitis B and non-A, Non-B HP Dienes, T Hütteroth, G Hess, SC Meuer	Hepatology	1987
Development of natural killer cells in human thymocyte culture: regulation by accessory cells ML Blue, H Levine, JF Daley, KA Craig, SF Schlossman	European Journal of Immunology	1987
Characterization of mononuclear cell subpopulations in normal fetal peripheral blood M Rainaut, M Pagniez, T Hercend, F Daffos, F Forestier	Human Immunology	1987
Differential surface marker expression in patients with Cd-16+ lymphoproliferative disorders: In vivo model for NK differentiation RA Bray, LR Gottschalk, AL Landay, HM Gebel	Human Immunology	1987
‘Nonspecific’ MHC-unrestricted killer cells and their receptors P Hersey, R Bolhuis	Immunology Today	1987
Lymphokine-activated killer cell activity RB Herberman, J Hiserodt, N Vujanovic, C Balch, E Lotzova, R Bolhuis, S Golub, LL Lanier, JH Phillips, C Riccardi, J Ritz, A Santoni, RE Schmidt, A Uchida	Immunology Today	1987
Studies on the calcium dependence of human NK cell killing J Ng, BB Fredholm, M Jondal	Biochemical Pharmacology	1987
T-cell prolymphocytic leukemia (T-PLL) with unique surface phenotype J Lohmeyer, M Hadam, A Ho, A Hesse, H Pralle	Blut Zeitschrift für die Gesamte Blutforschung	1987
Regulation of natural killer activity JR Ortaldo	Cancer and Metastasis Reviews	1987
Modern Trends in Human Leukemia VII R Neth, RC Gallo, MF Greaves, H Kabisch		1987
The IL-2 Receptor β Chain (p70): Role in Mediating Signals for LAK, NK, and Proliferative Activities JP Siegel, M Sharon, PL Smith, WJ Leonard	Science	1987
Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity RE Schmidt, GT Bartley, SS Lee, JF Daley, HD Royer, H Levine, EL Reinherz, SF Schlossman, J Ritz	Journal of Experimental Medicine	1986
Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity L Chatenoud, B Dugas, G Beaurain, M Touam, T Drueke, A Vasquez, P Galanaud, JF Bach, JF Delfraissy	Proceedings of the National Academy of Sciences	1986
Natural killer clones derived from fetal (25 wk) blood. Probing the human T cell receptor with WT31 monoclonal antibody A Nowill, P Moingeon, A Ythier, M Graziani, F Faure, L Delmon, M Rainaut, F Forrestier, C Bohuon, T Hercend	Journal of Experimental Medicine	1986
Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis JH Phillips, LL Lanier	Journal of Experimental Medicine	1986
A subset of natural killer cells in peripheral blood displays a mature T cell phenotype RE Schmidt, C Murray, JF Daley, SF Schlossman, J Ritz	Journal of Experimental Medicine	1986
Herpesvirus saimiri strain 11 immortalizes a restricted marmoset T8 lymphocyte subpopulation in vitro M Kiyotaki, RC Desrosiers, NL Letvin	Journal of Experimental Medicine	1986
Generation of monoclonal antibodies blocking cytotoxic reactions by human NK clones: Further characterization of a -kDa target cell receptor A Ythier, P Moingeon, M Fabbi, L Delmon, A Nowill, F Troelen, C Bohuon, T Hercend	Cellular Immunology	1986
Evidence for involvement of serine proteases in the late stages of the natural killer cell lytic reaction M Brogan, S Targan	Cellular Immunology	1986
A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity P Moingeon, A Ythier, G Goubin, F Faure, A Nowill, L Delmon, M Rainaud, F Forestier, F Daffos, C Bohuon, T Hercend	Nature	1986
Allospecific proliferative human T-cell clones acquire the cytotoxic effector function after three months in culture, in IL-2 conditioned medium LK Chen, A Bensussan, GF Burns, B Tourvieille, A Soulié, M Sasportes	Human Immunology	1986
Evidence for three types of human cytotoxic lymphocyte LL Lanier, JH Phillips	Immunology Today	1986
Class II antigens in Hashimoto thyroiditis J Möst, G Wick	Clinical Immunology and Immunopathology	1986
Immunobiology of complete molar pregnancy and gestational trophoblastic tumor RS Berkowitz, SA Umpierre, S Taylor-Emery, DP Goldstein, DJ Anderson	Cancer and Metastasis Reviews	1986
Leukocyte Typing II EL Reinherz, LM Nadler, BF Haynes, ID Bernstein		1986
Human thymic and peripheral blood non-MHC-restricted cytotoxic lymphocytes LL Lanier, JH Phillips		1986
Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis RP MacDermott, RE Schmidt, JP Caulfield, A Hein, GT Bartley, J Ritz, SF Schlossman, KF Austen, RL Stevens	Journal of Experimental Medicine	1985
Functional surface structures on human natural killer cells RE Schmidt, T Hercend, SF Schlossman, J Ritz	Klinische Wochenschrift	1985
Specific release of proteoglycans from human natural killer cells during target lysis RE Schmidt, RP MacDermott, G Bartley, M Bertovich, DA Amato, KF Austen, SF Schlossman, RL Stevens, J Ritz	Nature	1985
Proliferative responses of circulating human NK cells: delineation of a unique pathway involving both direct and helper signals A Ythier, L Delmon, E Reinherz, A Nowill, P Moingeon, Z Mishal, C Bohuon, T Hercend	European Journal of Immunology	1985
Analysis of T-Cell Receptor Gene Rearrangement and Expression in Human Natural Killer Clones J Ritz, TJ Campen, RE Schmidt, HD Royer, T Hercend, RE Hussey, EL Reinherz	Science	1985
Progress in Immunology IH Lepow	Progress in Immunology	1971

Citations to this article

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Abstract

Authors

Total citations by year

Citations to this article (220)

Sign up for email alerts